20 May 2013
Keywords: s-p, gains, approval, hayfever, drug, japan, schering-plough
Article | 28 July 2008
Schering-Plough KK, the Japanese arm of the US drug major, has received marketing approval for Nasonex (mometasone furoate monohydrate) Nasal ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.